|
Volumn 23, Issue 24, 2014, Pages 6644-6658
|
SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's disease
a b c c c b b a b a b b b a c b b b c b more.. |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMYLOID BETA PROTEIN;
AMYLOID BETA-PROTEIN (1-42);
APOLIPOPROTEIN E4;
NUCLEAR PROTEIN;
PEPTIDE FRAGMENT;
RNA BINDING PROTEIN;
SERINE ARGININE RICH SPLICING FACTOR;
TAU PROTEIN;
AGED;
ALZHEIMER DISEASE;
CEREBROSPINAL FLUID;
COGNITION;
FEMALE;
GENE EXPRESSION REGULATION;
GENETICS;
GENOME-WIDE ASSOCIATION STUDY;
HUMAN;
MALE;
PATHOLOGY;
PHOSPHORYLATION;
SIGNAL TRANSDUCTION;
SINGLE NUCLEOTIDE POLYMORPHISM;
AGED;
ALZHEIMER DISEASE;
AMYLOID BETA-PEPTIDES;
APOLIPOPROTEIN E4;
COGNITION;
FEMALE;
GENE EXPRESSION REGULATION;
GENOME-WIDE ASSOCIATION STUDY;
HUMANS;
MALE;
NUCLEAR PROTEINS;
PEPTIDE FRAGMENTS;
PHOSPHORYLATION;
POLYMORPHISM, SINGLE NUCLEOTIDE;
RNA-BINDING PROTEINS;
SERINE-ARGININE SPLICING FACTORS;
SIGNAL TRANSDUCTION;
TAU PROTEINS;
|
EID: 84969298076
PISSN: None
EISSN: 14602083
Source Type: Journal
DOI: 10.1093/hmg/ddu372 Document Type: Article |
Times cited : (38)
|
References (0)
|